Find Uproleselan manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Uproleselan [usan], Gmi-1271, Gmi-1271 free acid, Pe952anf83, 1983970-12-2, Uproleselan [inn]
Molecular Formula
C60H109N3O27
Molecular Weight
1304.5  g/mol
InChI Key
LYSYOXNOOPBOSC-NGSKMYNLSA-N
FDA UNII
PE952ANF83

Uproleselan
Uproleselan is a synthetic, glycomimetic molecule and E-selectin (CD62E) antagonist, with potential anti-thrombotic, antineoplastic and chemopotentiating activities. Upon administration, uproleselan binds to E-selectin expressed on endothelial cells and prevents their interaction with selectin-E ligand-expressing cancer cells. This may prevent tumor cell activation, migration and metastasis. GMI-1271 also interferes with the binding of selectin E-expressing vascular endothelial cells to selectin-E ligand-expressing monocytes and neutrophils, thereby disrupting their activation. Consequently, this inhibits both the activation of the coagulation cascade and thrombus formation. This agent also prevents both leukocyte activation and inflammation. E-selectin is a cell adhesion molecule involved in cell rolling, signaling and chemotaxis; it also plays a crucial role in inflammatory processes and cancer.
1 2D Structure

Uproleselan

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S)-2-[(2R,3R,4R,5R,6R)-3-acetamido-2-[(1R,2R,3S,5R)-3-ethyl-5-[2-[3-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoylamino]ethylcarbamoyl]-2-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxycyclohexyl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3-cyclohexylpropanoic acid
2.1.2 InChI
InChI=1S/C60H109N3O27/c1-5-44-38-45(39-46(55(44)90-60-54(70)53(69)51(67)41(2)86-60)88-59-50(63-42(3)65)56(52(68)48(40-64)89-59)87-47(58(72)73)37-43-9-7-6-8-10-43)57(71)62-13-12-61-49(66)11-14-75-17-18-77-21-22-79-25-26-81-29-30-83-33-34-85-36-35-84-32-31-82-28-27-80-24-23-78-20-19-76-16-15-74-4/h41,43-48,50-56,59-60,64,67-70H,5-40H2,1-4H3,(H,61,66)(H,62,71)(H,63,65)(H,72,73)/t41-,44-,45+,46+,47-,48+,50+,51+,52-,53+,54-,55+,56+,59+,60-/m0/s1
2.1.3 InChI Key
LYSYOXNOOPBOSC-NGSKMYNLSA-N
2.1.4 Canonical SMILES
CCC1CC(CC(C1OC2C(C(C(C(O2)C)O)O)O)OC3C(C(C(C(O3)CO)O)OC(CC4CCCCC4)C(=O)O)NC(=O)C)C(=O)NCCNC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC
2.1.5 Isomeric SMILES
CC[C@H]1C[C@H](C[C@H]([C@@H]1O[C@H]2[C@H]([C@@H]([C@@H]([C@@H](O2)C)O)O)O)O[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O[C@@H](CC4CCCCC4)C(=O)O)NC(=O)C)C(=O)NCCNC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC
2.2 Other Identifiers
2.2.1 UNII
PE952ANF83
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (2s)-2-(((2r,3r,4r,5r,6r)-3-acetamido-2-(((1r,2r,3s,5r)-5-((2-(4,7,10,13,16,19,22,25,28,31,34,37-dodecaoxaoctatriacontanamido)ethyl)carbamoyl)-3-ethyl-2-(alpha-l-galactopyranosyloxy)cyclohexyl)oxy)-5-hydroxy-6-(hydroxymethyl)oxan-4-yl)oxy)-3-cyc

2. Abi-701

3. Abi701

4. Gmi-1271

5. Gmi-1271 Free Acid

6. Gmi-1271 Sodium

7. Gmi-1687

8. Sodium (2s)-2-(((2r,3r,4r,5r,6r)-3-acetamido-2-(((1r,2r,3s,5r)-5-((2-(4,7,10,13,16,19,22,25,28,31,34,37-dodecaoxaoctatriacontanamido)ethyl)carbamoyl)-3-ethyl-2-(alpha-l-galactopyranosyloxy)cyclohexyl)oxy)-5-hydroxy-6-(hydroxymethyl)oxan-4-yl)oxy

9. Uproleselan Sodium

2.3.2 Depositor-Supplied Synonyms

1. Uproleselan [usan]

2. Gmi-1271

3. Gmi-1271 Free Acid

4. Pe952anf83

5. 1983970-12-2

6. Uproleselan [inn]

7. Uproleselan (usan/inn)

8. Unii-pe952anf83

9. Uproleselan [who-dd]

10. Chembl3989971

11. Gtpl11995

12. Gmi1271

13. Db14829

14. D11332

15. (2s)-2-(((2r,3r,4r,5r,6r)-3-acetamido-2-(((1r,2r,3s,5r)-5-((2-(4,7,10,13,16,19,22,25,28,31,34,37-dodecaoxaoctatriacontanamido)ethyl)carbamoyl)-3-ethyl-2-(alpha-l-galactopyranosyloxy)cyclohexyl)oxy)-5-hydroxy-6-(hydroxymethyl)oxan-4-yl)oxy)-3-cyclohexylpropanoic Acid

16. 4,7,10,13,16,19,22,25,28,31,34,37-dodecaoxaoctatriacontanamide, N-(2-((((1r,3r,4r,5s)-3-((2-(acetylamino)-3-o-((1s)-1-carboxy-2-cyclohexylethyl)-2-deoxy-bata-d-galactopyranosyl)oxy)-4-((6-deoxy-alpha-l-galactopyranosyl)oxy)-5-ethylcyclohexyl)carbonyl)amino)ethyl)-

2.4 Create Date
2013-07-15
3 Chemical and Physical Properties
Molecular Weight 1304.5 g/mol
Molecular Formula C60H109N3O27
XLogP3-2
Hydrogen Bond Donor Count9
Hydrogen Bond Acceptor Count27
Rotatable Bond Count52
Exact Mass1303.72484521 g/mol
Monoisotopic Mass1303.72484521 g/mol
Topological Polar Surface Area383 Ų
Heavy Atom Count90
Formal Charge0
Complexity1870
Isotope Atom Count0
Defined Atom Stereocenter Count15
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty